CPhI organises the most important and widespread series of global pharmaceutical events. As the host of key events in Asia, South America, Europe, and beyond, CPhl has become the preferred hub for establishing business connections, learning, growing, and conducting business for 500,000+ influential and respected pharma players from every section of the supply chain. With a 30-year tradition and an infrastructure fine-tuned to unite buyers, sellers, and industry trailblazers, CPhI expanded this iconic worldwide events portfolio into the most progressive mega-market of the world, North America.

The United States alone accounts for 40% of global pharmaceutical sales and is home to 6 of the top 11 pharmaceutical companies. Moreover, the US market offers an exceptional platform for community building and thought leadership, while serving as a hub for innovation. Most importantly, all of it comes to life at CPhI North America.

Aurigene Pharmaceutical Services Limited (APSL) is an integrated CDMO partner for global pharma companies. Our range of services covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to commercial-scale manufacturing of APIs and formulations. We have New Chemical and Biological Entities (NCEs/NBEs) development laboratories for the discovery phase to clinical phase III. Also, we have cGMP manufacturing facilities in the UK, Mexico, USA, and India. Our technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides, and oligonucleotides. Our large molecule discovery services include ADC, MAB, mRNA, CART-T as well as development services in MAB and protein therapeutics.